Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1992 Jan;83(1):113–120. doi: 10.1111/j.1349-7006.1992.tb02360.x

Anticellular and Antitumor Activity of Duocarmycins, Novel Antitumor Antibiotics

Katsushige Gomi 1, Eiji Kobayashi 1, Katsunori Miyoshi 1, Tadashi Ashizawa 1, Akihiko Okamoto 1, Tatsuhiro Ogawa 1, Shigeo Katsumata 1, Akira Mihara 1, Masami Okabe 1, Tadashi Hirata 1
PMCID: PMC5918644  PMID: 1544867

Abstract

The anticellular and antitumor activities of novel antitumor antibiotics, duocarmycins (DUMs), were examined against human and murine tumor cells. DUMs consist of live compounds, A, B1, B2, C1, and C2, which possess a pharmacophore similar to that of CC‐1065, a previously isolated antibiotic. Among them, DUMA exhibited ultrapotent growth‐inhibitory activity with an IC50 value of 6 pM against human uterine cervix carcinoma HeLa S3 cells. DUMA and DUMB1 also inhibited the growth of adriamycin (ADM)‐resistant lines of human nasopharynx carcinoma KB cells and breast carcinoma MCF‐7 cells as well as their sensitive lines. DUMs inhibited the growth of s.c.‐inoculated murine tumors such as B16 melanoma, sarcoma 180, M5076 sarcoma and colon 26. DUMs were also significantly effective in increasing the lifespan of i.p.‐inoculated B16 melanoma‐bearing mice, although their effect was marginal against other i.p.‐inoculated tumors. As a whole, DUMB1 exhibited superior activity to the other four compounds. DUMB1 rapidly inhibited the incorporation of [3H]‐TdR into macromolecules of HeLa S3 cells as compared with that of [3H]UR or [3H]leucine. DNA strand breaks were detected in DUMB1 ‐treated HeLa S3 cells by agarose gel electrophoresis with a contour‐clamped homogeneous electric field apparatus. These results indicate that DUMs possess interesting biological activities as DNA‐targeting antitumor antibiotics.

Keywords: Antitumor activity, Antibiotic, Duocarmycin, DNA strand break

Full Text

The Full Text of this article is available as a PDF (446.7 KB).

REFERENCES

  • 1. ) Ichimura , M. , Muroi , K. , Asano , K. , Kawamoto , I. , Tomita , F. , Morimoto , M. and Nakano , H.DC89‐Al, a new antitumor antibiotic from Streptomyces . J. Antibiot. , 41 , 1285 – 1288 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Takahashi , I. , Takahashi , K. , Ichimura , M. , Morimoto , M. , Asano , K. , Kawamoto , I. , Tomita , F. and Nakano , H.Duocarmycin A, a new antitumor antibiotic from Streptomyces . J. Antibiot. , 41 , 1915 – 1917 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Yasuzawa , T. , Iida , T. , Muroi , K. , Ichimura , M. , Takahashi , K. , and Sano , H.Structures of duocarmycins, novel antitumor antibiotics produced by Streptomyces sp . Chem. Pharm. Bull. , 36 , 3728 – 3731 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Ogawa , T. , Ichimura , M. , Katsumata , S. , Morimoto , M. and Takahashi , K.New antitumor antibiotics, duocarmycins B1 and B2 . J. Antibiot. , 42 , 1299 – 1301 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Hanka , L. J. , Dietz , A. , Gerpheide , S. A. , Kuentzel , S. L. and Martin , D. G.CC‐1065 (NSC‐298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism . J. Antibiot. , 31 , 1211 – 1217 ( 1978. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Martin , D. G. , Biles , C. , Gerpheide , S. A. , Hanka , L. J. , Krueger , W. C. , McGovren , J. P. , Mizsak , S. A. , Neil , G. L. , Stewart , J. C. and Visser , J.CC‐1065 (NSC 298223), a potent new antitumor agent. Improved production and isolation, characterization and antitumor activity . J. Antibiot , 34 , 1119 – 1125 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Li , L. H. , Swenson , D. H. , Schpok , S. L. F. , Kuentzel , S. L. , Dayton , B. D. and Krueger , W. C.CC‐1065 (NSC 298223), a novel antitumor agent that interacts strongly with double‐stranded DNA . Cancer Res. , 42 , 999 – 1004 ( 1982. ). [PubMed] [Google Scholar]
  • 8. ) Boger , D. L. , Invergo , B. J. , Coleman , R. S. , Zarrinmayeh , H. , Kitos , P. A. , Thompson , S. C. , Leong , T. and McLaughlin , L. W.A demonstration of the intrinsic importance of stabilizing hydrophobic binding and non‐covalent van der Waals contacts dominant in the non‐covalent CC‐1065/B‐DNA binding . Chem.-Biol. Interact. , 73 , 29 – 52 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Warpehoski , M. A. , Gebhard , I. , Kelly , R. C. , Krueger , W. C. , Li , L. H. , McGovren , J. P. , Prairie , M. D. , Wicnienski , N. and Wierenga , W.Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC‐1065 . J. Med. Chem. , 31 , 590 – 603 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Tang , M.‐S. , Lee , C.‐S. , Doisy , R. , Ross , L. , Needham‐VanDevanter , D. R. and Hurley , L. H.Recognition and repair of the CC‐1065‐(N3‐adenine)‐DNA adduct by the UVRABC nucleases . Biochemistry , 27 , 893 – 901 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Boger , D. L. , Ishizaki , T. and Zarrinmayeh , H.Synthesis and preliminary evaluation of agents incorporating the pharmacophore of the duocarmycin/pyrindamycin alkylation subunit: identification of the CC‐1065/duocarmycin common pharmacophore . J. Org. Chem. , 55 , 4499 – 4502 ( 1990. ). [Google Scholar]
  • 12. ) Shen , D.‐W. , Cardarelli , C. , Hwang , J. , Cornwell , M. , Richert , N. , Ishii , S. , Pastan , I. and Gottesman , M. M.Multiple drug‐resistant human KB carcinoma cells independently selected for high‐level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins . J. Biol. Chem. , 261 , 7762 – 7770 ( 1986. ). [PubMed] [Google Scholar]
  • 13. ) Fairchild , C. R. , Ivy , S. P. , Kao‐Shan , C.‐S. , Whang‐Peng , J. , Rosen , N. , Israel , M. A. , Melera , P. W. , Cowan , K. H. and Goldsmith , M. E.Isolation of amplified and overexpressed DNA sequences from adriamycin‐resistant human breast cancer cells . Cancer Res. , 47 , 5141 – 5148 ( 1987. ). [PubMed] [Google Scholar]
  • 14. ) Gomi , K. , Morimoto , M. and Nakamizo , N.Characteristics of antiviral and anticellular activities of human recombinant interferon‐γ . Jpn. J. Cancer Res. , 76 , 224 – 234 ( 1985. ). [PubMed] [Google Scholar]
  • 15. ) Geran , R. I. , Greenberg , N. H. , MacDonald , M. M. , Schumacher , A. M. and Abbott , B. J.Protocols for screening chemical agents and natural products against animal tumors and other biological systems . Cancer Chemother. Rep. Part III , 3 , 1 – 103 ( 1972. ). [Google Scholar]
  • 16. ) Fojo , A. T. , Ueda , K. , Slamon , D. J. , Popiack , D. G. , Gottesman , M. M. and Pastan , I.Expression of a multi‐drug‐resistance gene in human tumors and tissues . Proc. Natl. Acad. Sci. USA , 84 , 265 – 269 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. ) Cleare , M. J. and Hoeschele , J. D.Antitumour platinum compounds. Relationship between structure and activity . Platinum Metals Rev. , 17 , 2 – 13 ( 1973. ). [Google Scholar]
  • 18. ) McGovren , J. P. , Clarke , G. L. , Pratt , E. A. and DeKoning , T. F.Preliminary toxicity studies with the DNA‐binding antibiotic CC‐1065 . J. Antibiot. , 37 , 63 – 70 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Wevrick , R. and Willard , H. F.Long‐range organization of tandem arrays of a satellite DNA at the centromeres of human chromosomes: high‐frequency array‐length polymorphism and meiotic stability . Proc. Natl. Acad. Sci. USA , 86 , 9394 – 9398 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Tomasz , M. , Lipman , R. , Chowdary , D. , Pawlak , J. , Verdine , G. L. and Nakanishi , K.Isolation and structure of a covalent cross‐link adduct between mitomycin C and DNA . Science , 235 , 1204 – 1208 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Ueda , K. , Morita , J. and Komano , T.Induction of single strand scission in bacteriophage φX174 replicative form I DNA by mitomycin C . J. Antibiot. , 34 , 317 – 322 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Pritsos , C. A. and Sartorelli , A. C.Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics . Cancer Res. , 46 , 3528 – 3532 ( 1986. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES